22 July 2022
PharmEasy has momentarily given up on its effort to go public. The company is aiming to raise $200 million through a private placement, albeit at a lower valuation than before. This implies that it will now provide investors a larger stake than before for raising the same amount of money. Some estimates place the corporation's willingness to accept a 25% valuation reduction.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Mutual Fund License No.:
IRDA Code (1):
IRDA Code (2):
Startup India Certificate No.:
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India